Home > Financial Ratios > MEDICAMEN BIOTECH

MEDICAMEN BIOTECH
Core EBITDA Growth

    Back to All Ratios
MEDICAMEN BIOTECH is part of below Screeners ↓
Top Undervalued Small Cap Stocks
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for MEDICAMEN BIOTECH
Please provide your vote to see the results

MEDICAMEN BIOTECH Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Core EBITDA Growth(%) -20.02-3.593.8626.35-4.60

What is the latest Core EBITDA Growth ratio of MEDICAMEN BIOTECH ?

The latest Core EBITDA Growth ratio of MEDICAMEN BIOTECH is -20.02 based on Mar2025 Consolidated results.
Year Core EBITDA Growth
Mar2025-20.02
Mar2024-3.59
Mar20233.86
Mar202226.35
Mar2021-4.60

How is Core EBITDA Growth of MEDICAMEN BIOTECH Trending?

Years Core EBITDA Growth % Change
Mar2025 -20.02
Negative
Mar2024 -3.59
Negative
Mar2023 3.86
-85.35
Mar2022 26.35
Positive
Mar2021 -4.6 -

Other Financial Ratios of MEDICAMEN BIOTECH


Compare Core EBITDA Growth ratio of peers of MEDICAMEN BIOTECH

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
MEDICAMEN BIOTECH ₹512.5 Cr 4.9% 27.7% -27.1% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹405,452.0 Cr -0.3% 6% -10.5% Stock Analytics
DIVIS LABORATORIES ₹179,089.0 Cr 3.9% 18.6% 14.5% Stock Analytics
CIPLA ₹121,299.0 Cr -5.2% NA 2.5% Stock Analytics
TORRENT PHARMACEUTICALS ₹120,456.0 Cr -1% -1.2% 8.7% Stock Analytics
DR REDDYS LABORATORIES ₹99,965.9 Cr -6.8% -2.1% -8.4% Stock Analytics


MEDICAMEN BIOTECH Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
MEDICAMEN BIOTECH

4.9%

27.7%

-27.1%

SENSEX

-0.3%

4.5%

5.7%


You may also like the below Video Courses